MACKENZIE CHEEK: Open Payments
NPI 1215472360 · HARTWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 55 payments from 14 companies in 2025. Trend: 2023 $1,116 · 2024 $1,184 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $167 |
| AstraZeneca Pharmaceuticals LP | 10 | $161 |
| Novo Nordisk Inc | 9 | $143 |
| PFIZER INC. | 5 | $107 |
| Lilly USA, LLC | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
Products named: JARDIANCE, NURTEC ODT, Wegovy, Kerendia, BREZTRI, FARXIGA, MOUNJARO, REXULTI.
Industry payments across GA — which companies pay providers there.
